As a general guideline, it is suggested that within a particular antimicrobial class, primary (group A) agents should be reported first and secondary (group B) agents should be reported only if

A) the physician insists that a secondary agent be reported.
B) the hospital pharmacy no longer stocks the group A agent.
C) the patient cannot tolerate the primary agents.
D) the FDA has recalled the primary agents.